Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA4 | P22748 | 2/20 | 0.54 |
| ▸ | CA6 | P23280 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.42 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.42 |
| ▸ | ITGAL | P20701 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | ADK | P55263 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29597557 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL28901253 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CA1CA4CA6CA12 | |
| Formic Acid SCHEMBL11192981 | 0.88 | CA1 (0.48) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL29197198 | 0.80 | ALDH1A1 (0.38) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL28678145 | 0.79 | ALDH1A1 (0.37) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL29152421 | 0.70 | ALDH1A1 (0.54) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL29351086 | 0.70 | CA12 (1.00) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL8621 | 0.70 | CA12 (1.00) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL30958273 | 0.70 | CA12 (1.00) | ALDH1A1CA1CA4CA6CA12 | |
| SCHEMBL89002 | 0.70 | ALDH1A1 (1.00) | ALDH1A1CA1CA4CA6CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349796-B | Cationic metal complex iridium-iminoquinoline crystal material and preparation method thereof | 江苏大学 | 2024-03-22 | — | — | CN | claimed |
| CN-114989137-B | Chiral imine-containing quinoline imidazoline compound and metal complex thereof, preparation method and application | 浙江大学 | 2024-03-01 | — | — | CN | claimed |
| CN-117466891-A | Preparation method of 2-fluoropyrazolo [1,5-a ] pyridine compound | 西北师范大学 | 2024-01-30 | — | — | CN | claimed |
| CN-113880822-B | Chiral imine quinoline oxazoline-containing compound and metal complex thereof, preparation method and application | 浙江大学 | 2023-09-19 | — | — | CN | claimed |
| CN-115516313-A | Activity-based mass spectrometry of host cell proteins | 瑞泽恩制药公司 | 2022-12-23 | — | — | CN | claimed |
| CN-114349796-A | Cationic metal complex iridium-iminoquinoline crystal material and preparation method thereof | 江苏大学 | 2022-04-15 | — | — | CN | claimed |
| CN-110396116-A | Ketone-imidazoline -2- imine ligand [N, O] bidentate nickel, palladium complex and the preparation method and application thereof | UNIV NATIONAL DONG HWA | 2019-11-01 | — | — | CN | claimed |
| CN-106866527-B | A kind of synthetic method of quinoline -2- imine derivative | 北京大学 | 2019-09-06 | — | — | CN | claimed |
| CN-106866527-A | A kind of synthetic method of the imine derivative of quinoline 2 | 北京大学 | 2017-06-20 | — | — | CN | claimed |
| US-20110061179-A1 | BLUE POLYMERIC HAIR DYES | BASF SE (US) | 2011-03-17 | — | — | US | claimed |
| EP-2238205-A1 | BLUE POLYMERIC HAIR DYES | BASF SE (DE) | 2010-10-13 | — | — | EP | claimed |
| WO-2009090124-A1 | BLUE POLYMERIC HAIR DYES | BASF SE (DE) | 2009-07-23 | — | — | WO | claimed |
| EP-4701782-A1 | CATALYST SYSTEM AND ETHYLENE OLIGOMERIZATION PROCESS FOR THE PREPARATION OF LINEAR ALPHA OLEFINS | Chevron Phillips Chemical Company LP (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4701783-A1 | PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2026-03-04 | — | — | EP | disclosed |
| CN-121013762-A | Phosphine-imino-quinolines and related ligands for use in ethylene oligomerization processes | 切弗朗菲利浦化学公司 | 2025-11-25 | — | — | CN | disclosed |
| US-20250346619-A1 | Phosphino-Quinoline-Pyridine Ligands and Methods | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-11-13 | — | — | US | disclosed |
| EP-0724570-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-08-07 | — | — | EP | disclosed |
| CN-1123275-A | Substituted quinoline derivatives, method for the production thereof and use thereof | HOECHST AG (DE) | 1996-05-29 | — | — | CN | disclosed |
| CN-1083477-A | 4-imino-quinoline, its preparation method and application thereof | HOECHST AG (DE) | 1994-03-09 | — | — | CN | disclosed |
| US-4077960-A | YELLOW, POLYMERS | TEIJIN LIMITED (JA) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346619-A1 | Phosphino-Quinoline-Pyridine Ligands and Methods | PHOSPHO1, PEBP1, PNPO | ALDH1A1 4445/4885CA1 2126/4885CA4 2342/4885 |
| US-20110061179-A1 | BLUE POLYMERIC HAIR DYES | CUTA, IK, TYR | ALDH1A1 2076/4885CA1 4063/4885CA4 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.